Epoch Biodesign Advances Recycling Tech with $18.3 Million Series A

In a pivotal development for the recycling technology sector, London-based biotech company Epoch Biodesign has raised $18.3 million in its Series A funding round. This round saw significant participation from venture capital firms, led by Extantia Capital, along with Mundi Ventures on behalf of Inditex, Lowercarbon Capital, Happiness Capital, Kibo Invest, and Day One Ventures, as well as a $1 million grant from the UK government. Epoch Biodesign focuses on developing cutting-edge enzymatic recycling technologies for plastics like Nylon and PET, aiming to facilitate a comprehensive circular economy in the plastics industry. CEO and Founder Jacob Nathan highlights the company's strategy of using AI and enzyme technology to transform plastic waste into valuable chemicals, emphasizing Epoch's potential to make all plastics recyclable competitively. Epoch's technology has attracted partnerships across various sectors, from performance apparel to automobiles, showcasing its promise for industry-wide sustainability impact. This funding will support the construction of Epoch's first plant, the expansion of its enzyme library, and the commencement of service offerings to major global textile clients.